This review synthesizes recent updates from four major international guidelines on the management of atrial fibrillation, focusing on rhythm control and thromboprophylaxis.
Answers are grounded in this paper and cite their sources.
AF management requires awareness of guideline differences in rhythm control and anticoagulation; synthesis extends cross-society comparison but leaves optimal alignment open.
Atrial fibrillation is one of the most common and complex cardiac arrhythmias. Using currently available evidence, leading medical societies have established recommendations for the optimal management of atrial fibrillation. These guidelines have recently been updated by 4 consensus groups: the European Society of Cardiology, the American College of Chest Physicians, the Canadian Cardiovascular Society, and a task force of 3 societies from the United States: the American College of Cardiology Foundation, the American Heart Association, and the Heart Rhythm Society. The present review focused on the similarities and differences among these recently updated guidelines. Key revisions included updated information on newer treatments for rhythm control, treatment options to reduce atrial fibrillation complications, and updated anticoagulant management for thromboprophylaxis.
No takes yet. Share an insight, caveat, or question.
Anne B. Curtis (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: